As of October 2024, Bioxytran has a market cap of $11.27M. This makes Bioxytran the world's 32355th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $18.80M | -13.33% |
2023 | $21.70M | -68.75% |
2022 | $69.43M | 20.00% |
2021 | $57.86M | 66.67% |
2020 | $34.71M | -15.49% |
2019 | $41.08M | -44.31% |
2018 | $73.77M | -75.71% |
2017 | $303.75M | 302.29% |
2016 | $75.50M | -62.34% |
2015 | $200.48M | -88.45% |
2014 | $1.74B | -86.44% |
2013 | $12.80B | 31.11% |
2012 | $9.76B | -43.75% |
2011 | $17.36B | 20.00% |
2010 | $14.46B | - |